Organovo (NASDAQ:ONVO) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVOFree Report) in a research note published on Thursday morning. The firm issued a sell rating on the medical research company’s stock.

Organovo Price Performance

Shares of ONVO stock opened at $0.91 on Thursday. The stock’s fifty day moving average price is $1.01 and its 200 day moving average price is $1.05. Organovo has a 1-year low of $0.85 and a 1-year high of $2.05. The company has a market cap of $13.02 million, a price-to-earnings ratio of -0.42 and a beta of 0.68.

About Organovo

(Get Free Report)

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

Featured Articles

Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.